BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsoukas J, Apostolopoulos V, Zulli A, Moore G, Kelaidonis K, Moschovou K, Mavromoustakos T. From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy. Molecules 2021;26:618. [PMID: 33504092 DOI: 10.3390/molecules26030618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kalasariya HS, Patel NB, Gacem A, Alsufyani T, Reece LM, Yadav VK, Awwad NS, Ibrahium HA, Ahn Y, Yadav KK, Jeon BH. Marine Alga Ulva fasciata-Derived Molecules for the Potential Treatment of SARS-CoV-2: An In Silico Approach. Mar Drugs 2022;20:586. [PMID: 36135775 DOI: 10.3390/md20090586] [Reference Citation Analysis]
2 Moore GJ, Ridgway H, Kelaidonis K, Chasapis CT, Ligielli I, Mavromoustakos T, Bojarska J, Matsoukas JM. Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System. Molecules 2022;27:4854. [PMID: 35956801 DOI: 10.3390/molecules27154854] [Reference Citation Analysis]
3 Matsoukas JM, Gadanec LK, Zulli A, Apostolopoulos V, Kelaidonis K, Ligielli I, Moschovou K, Georgiou N, Plotas P, Chasapis CT, Moore G, Ridgway H, Mavromoustakos T. Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2. Biomedicines 2022;10:1731. [PMID: 35885036 DOI: 10.3390/biomedicines10071731] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Apostolopoulos V, Bojarska J, Chai T, Feehan J, Kaczmarek K, Matsoukas JM, Paredes Lopez O, Saviano M, Skwarczynski M, Smith-carpenter J, Venanzi M, Wolf WM, Zielenkiewicz P, Ziora ZM. New Advances in Short Peptides: Looking Forward. Molecules 2022;27:3635. [DOI: 10.3390/molecules27113635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bojarska J. Advances in Research of Short Peptides. Molecules 2022;27:2446. [PMID: 35458644 DOI: 10.3390/molecules27082446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moore GJ, Pires JM, Kelaidonis K, Gadanec LK, Zulli A, Apostolopoulos V, Matsoukas JM. Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19. Biomolecules 2021;11:979. [PMID: 34356603 DOI: 10.3390/biom11070979] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Hossain MK, Hassanzadeganroudsari M, Feehan J, Apostolopoulos V. COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate? Vaccines (Basel) 2021;9:241. [PMID: 33802086 DOI: 10.3390/vaccines9030241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 2021;9:525. [PMID: 33806624 DOI: 10.3390/microorganisms9030525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]